Navigation Links
The New England Journal of Medicine Publishes Study Showing LigoCyte's Norovirus Vaccine Demonstrates Protection Against Illness
Date:12/8/2011

ines that are designed to cover multiple genetic varieties (or 'strains') of norovirus. LigoCyte's vaccine formulation also includes the adjuvant Monophosphoryl Lipid A, provided under license from GlaxoSmithKline PLC (NYSE: GSK), and the nasal vaccine incorporates chitosan. This application of chitosan (ChiSys®) has been licensed from Archimedes Development Ltd.(1)

A clinical study of a multi-strain (bivalent) formulation of LigoCyte's norovirus vaccine is ongoing. Preliminary results from that study were presented by one of the principal investigators in the study, Sharon Frey, M.D., from the Saint Louis University Center for Vaccine Development at the Saint Louis University School of Medicine, at the Infectious Diseases Society of America (IDSA) 2011 Annual Meeting on October 21 in Boston, Mass. Data presented at the meeting indicate that the bivalent vaccine induces immune responses that are even more potent than the single strain (monovalent) vaccine.

About LigoCyte

LigoCyte is a private, clinical-stage biopharmaceutical company focused on developing novel vaccines for gastrointestinal and respiratory indications. LigoCyte's expertise in virus-like particle technology supports a pipeline of enhanced product candidates, including vaccines against norovirus, influenza, respiratory syncytial virus and rotavirus. LigoCyte has funded its product development efforts through a mix of private investment as well as grants and contracts administered through the National Institutes of Health and the U.S. Department of Defense. LigoCyte's investors include Forward Ventures, JAFCO, Novartis Venture Fund, Fidelity Biosciences, MedImmune Ventures, Athenian Venture Partners and MC Life Sciences Ventures (Mitsubishi International Corporation). GlaxoSmithKline is also a shareholder of the company. For addi
'/>"/>

SOURCE LigoCyte Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Bellicum Announces Publication in The New England Journal of Medicine Demonstrating Complete Reversal of Serious Immune Condition in Hematopoietic Stem Cell Transplant Patients
2. NxStage: NIH Study Published in New England Journal of Medicine Adds to Growing Body of Evidence in Support of More Frequent Hemodialysis
3. New Study Published in New England Journal of Medicine Shows Investigational BIBF 1120 Demonstrated Positive Trend in Reducing Lung Function Loss in Idiopathic Pulmonary Fibrosis
4. Fuse Science Partners With the New England Consulting Group to Advance Technology Licensing Efforts in Pharmaceutical and OTC Categories
5. New Phase 2 Data Published in New England Journal of Medicine Show Bardoxolone Methyl Sustained Improvement in Measure of Kidney Function (eGFR) Over 52 Weeks in Patients With Moderate to Severe Chronic Kidney Disease and Type 2 Diabetes
6. NxStage Founder and CEO Jeffrey Burbank Named Ernst & Young Entrepreneur of the Year® 2011 New England Award Winner
7. Pivotal Phase 3 Study Published in The New England Journal of Medicine (NEJM) Finds Overall Survival of Patients with Metastatic Castration-Resistant Prostate Cancer is Significantly Improved with ZYTIGA™ (abiraterone acetate)
8. New England Biolabs Expands its Distribution Network through Collaborations in India and the Netherlands
9. River Valley Community College and Medical Messenger Team Up to Prepare the Future Nurses of New England
10. Technology Collaboration Between New England Biolabs and Sequenom Delivers First Product for Epigenetics
11. Hospitalists at New England Baptist Hospital Choose MedAptus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... 2015   IBA Molecular, a global leader ... that it has signed a definitive agreement to sell ... NA), to Illinois Health and Science (IHS). Under IHS ownership, ... company headquartered in Dulles, Virginia , ... new product and footprint synergies. IBA Molecular is jointly ...
(Date:4/17/2015)... April 17, 2015 TWi Pharmaceuticals, Inc. ("TWi", ... Pharmaceuticals USA , has obtained state ... States.  It has been in close contact with the ... to have its own label specialty generic products sold ... U.S. pharma market. According to IMS Health, ...
(Date:4/16/2015)... 16, 2015  Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) ... 2015 on Wednesday, May 6, 2015, following the close of ... investor conference call and live webcast on the same day ... and discuss the financial results.  To access ... under the "Investors" link.  Please log onto the webcast prior ...
Breaking Medicine Technology:Health Care System to Acquire IBA Molecular North America 2Health Care System to Acquire IBA Molecular North America 3Alexza to Report 2015 First Quarter Financial Results and Provide Corporate Update on Wednesday, May 6, 2015 2Alexza to Report 2015 First Quarter Financial Results and Provide Corporate Update on Wednesday, May 6, 2015 3
... Va., Nov. 9, 2010 MicroAire Surgical Instruments LLC ... an agreement to settle a suit accusing Arthrex of ... the patented technology that MicroAire owns for minimally invasive ... K. Moon of the U.S. District Court for the ...
... MYSTIC, Conn., Nov. 9, 2010 Amarin Corporation plc (Nasdaq: ... Wednesday, November 10, 2010 at 11:00 am Eastern Time (4:00 ... the third quarter, including a progress update of the Company,s ... trials of its lead product candidate AMR101 for treating elevated ...
Cached Medicine Technology:MicroAire and Arthrex Agree to Amicable Settlement on ECTR Patent 2Amarin Corporation to Host Investor Conference Call on Wednesday, November 10, 2010 2
(Date:4/17/2015)... John Evans, a Gardant affordable assisted ... from 2 p.m. to 3 p.m. on April 24. ... Ct. in Pekin, Illinois, serves older adults of all ... to maintain their independence. , Becky Baker will entertain ... be served during the luau. , For more information, ...
(Date:4/17/2015)... 17, 2015 ERGO-Pedic Products, LLC, which ... two new products to help a broader range of ... relief are the second most common visitors to doctors. ... designed specifically to help relieve sitting pain. Then, only ... thousands of happy customers later, we began getting questions ...
(Date:4/17/2015)... (PRWEB) April 17, 2015 Alcohol and ... Dependence (NCADD) notes that drinking and driving has been ... At the same time, the link between alcohol and ... domestic abuse and violence and sexual assault, and their ... to the NCADD, 5.3 million adults in America were ...
(Date:4/17/2015)... “We have seen healing, a lot of healing, ... said Chaplain Shawn Kafader of Friendship Village. “People have ... anything to contribute have created beautiful pieces of art.” For ... therapy program that was launched to benefit residents of the ... of the Art Institute in Chicago, worked as an intern ...
(Date:4/17/2015)... D.C. (PRWEB) April 17, 2015 In ... issued the following statement: “On Wednesday April 15th, the ... and adopted a resolution recognizing the Armenian Genocide, “paying ... memory of the one-and-a-half million innocent Armenian victims who ... Christians (IDC) extols the EU for this timely and ...
Breaking Medicine News(10 mins):Health News:John Evans Supportive Living Community Prepares for Party on the Patio 2Health News:Seat Cushion Company Credits Customer Driven Design For Two New Products 2Health News:Narconon Arrowhead Raises Awareness on Alcohol Related Prevention 2Health News:Narconon Arrowhead Raises Awareness on Alcohol Related Prevention 3Health News:Healing At Friendship Village Due To Art Therapy 2Health News:In Defense of Christians Condemns Armenian Genocide 2Health News:In Defense of Christians Condemns Armenian Genocide 3
... the most serious adverse effects, yet there are also many ... first report from the National Register of Adverse Effects from ... "The Register gives us a better overview of the ... and who experiences them. Then we can make an assessment ...
... Women with ovarian cancer could be helped by a new ... a conference will hear this week. Researchers at ... doctors to personalise treatment programmes so that patients receive the ... from Ireland to identify six subgroups of the disease, each ...
... 30 (HealthDay News) -- Although stress can exacerbate multiple sclerosis ... the disease in the first place, new research indicates. ... ranging in age from 24 to 55, from the Nurses ... about their levels of stress both at home and at ...
... BROOK, Ill. Functional magnetic resonance imaging (fMRI) may ... to researchers at Columbia University in New York City, ... autistic children. Results of their study appear online and ... Autism is a spectrum disorder characterized by repetitive behaviors ...
... antibiotic resistance called New Delhi metallo--lactamase-1 (NDM-1), endemic in ... in two people in the Toronto area, one of ... in CMAJ ( Canadian Medical Association Journal ... outlines challenges and approaches to managing and identifying this ...
... News) -- ,In the wake of tennis star Serena Williams, ... College of Foot and Ankle Surgeons has a reminder: it,s ... caused when blood clots travel to the lungs, often from ... Women are at higher risk than men, as are overweight ...
Cached Medicine News:Health News:Cosmetics can cause serious adverse effects 2Health News:Targeted testing offers treatment hope for ovarian cancer patients 2Health News:New research may lead to improved diagnosis of autism 2Health News:New Delhi metallo-beta-lactamase-1 enzyme acquired in Canada 2Health News:Take Steps to Prevent Pulmonary Embolisms 2
... Iodine Prep Solution is appropriate for ... wet soak or spray); disinfecting of ... treatment of lacerations and abrasions. It ... agent in hospital and office procedures, ...
Pre-Saturated Sponge Sticks...
... trays to dry trays to specialty vaginal ... Cardinal Health offers the widest offering in ... components that are proven to be safe ... of surgical site infections. Cardinal Health Scrub ...
These simple but effective single-dose, hands-off, ampulized applicators have revolutionized skin preparation in hospitals....
Medicine Products: